Clinical Trials Sponsored by Dr. Schär AG / SPA

Total 7 results

Dr. Schär AG / SPA

Completed

Market Research - Acceptability Study for a Range of MCT Products

Epilepsy | Ketosis | Malabsorption | Fatty Acid Oxidation Disorder | Ketogenic Diet

United Kingdom
Dr. Schär AG / SPA

Completed

Market Research - Acceptability Study for a New PKU Protein Substitute

Phenylketonurias | Inborn Errors of Metabolism | Metabolic Disease | PKU

United Kingdom
Dr. Schär AG / SPA

Completed

Market Research - Acceptability Study for New MCT Fat Products

Epilepsy | Ketosis | Malabsorption | Fatty Acid Oxidation Disorder | Ketogenic Diet | Medium Chain Triglycerides

United Kingdom
Dr. Schär AG / SPA

Completed

A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula (CHARM)

Allergy;Food

Italy, Spain
Dr. Schär AG / SPA

Completed

Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorder

Russian Federation
Dr. Schär AG / SPA

Completed

Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute

Phenylketonurias | Inborn Errors of Metabolism | Metabolic Disease | PKU

United Kingdom
Dr. Schär AG / SPA
Slb Pharma

Recruiting

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3B

France

3

Subscribe